Invitrogen Reaches Key Milestone in its Agreement with Blue Heron Biotechnology
News Oct 19, 2007
Invitrogen Corporation has reached a key milestone in its agreement with Blue Heron Biotechnology and is now the co-exclusive worldwide distributor with Blue Heron for its custom gene synthesis services.
Blue Heron Biotechnology says that its proprietary GeneMaker® platform can synthesize gene sequences with perfect accuracy which makes it ideal for researchers studying anything from single genes up to entire genomes as in the biofuels and synthetic biology markets.
Researchers worldwide are increasingly turning to synthetic genes as a convenient, cost-effective alternative for traditional cloning. Synthetic genes have allowed pharmaceutical and biotechnology companies to speed the drug discovery process by rapidly and accurately synthesizing genes of interest that are in turn used to produce novel proteins, new vaccines and diagnostics.
"For decades, researchers have depended on Invitrogen's cloning platforms and gene collections to advance their gene discovery and functional genomics experiments. With new technologies that allow the economical production of synthetic genes, researchers can expand the possibilities of science," said Dr. Balwant Patel, general manager for Cloning and Protein Expression at Invitrogen.
"Our relationship with Blue Heron means that our customers will explore those possibilities with the best synthetic genetics technologies and the most highly regarded cloning and expression platforms available commercially," Dr. Patel added.
"This relationship creates unique opportunities to serve the needs of the research community. We are very enthusiastic about bringing Blue Heron's technological leadership in gene synthesis to Invitrogen's unmatched worldwide customer base," said John Fess, CEO of Blue Heron.
New Cell-weighing Technique Helps Predict How Drugs Affect Cancer CellsNews
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will affect cancer cells taken from multiple-myeloma patients.READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE